ANL
Adlai Nortye Ltd.
NASDAQ · Healthcare · Biotechnology · KY
$15.74
+3.01%0
Insider buys (3m)
2
Insider sells (3m)
-$164.6K
Net value (3m)
+52.3%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Ye Xiaofeng · officer: CFO | Sale | 6,000 | $14 |
| Aug 26, 2026 | Ye Xiaofeng · officer: CFO | Sale | 5,667 | $14 |
| May 21, 2026 | LU YANG · director, 10 percent owner, officer: CEO | Sale | 10 | $13 |
| Apr 17, 2008 | CONSIDINE TERRY · director, 10 percent owner, officer: Chairman & CEO | M-Exempt | 300,000 | $19 |
| Apr 17, 2008 | CONSIDINE TERRY · director, 10 percent owner, officer: Chairman & CEO | F-InKind | 248,910 | $21 |
| Apr 7, 2008 | RHODES THOMAS L · director | M-Exempt | 100,000 | $19 |
| Apr 7, 2008 | RHODES THOMAS L · director | F-InKind | 93,389 | $22 |
| Feb 19, 2008 | BLATZ ROBERT G · officer: President and COO | A-Award | 35,000 | $0.00 |
| Feb 19, 2008 | BLATZ ROBERT G · officer: President and COO | A-Award | 231 | $0.00 |
| Feb 19, 2008 | BLATZ ROBERT G · officer: President and COO | A-Award | 59,880 | $20 |
| Feb 19, 2008 | CONSIDINE TERRY · director, 10 percent owner, officer: Chairman & CEO | A-Award | 5,000 | $0.00 |
| Feb 19, 2008 | BLATZ ROBERT G · officer: President and COO | A-Award | 30,000 | $0.00 |
| Feb 19, 2008 | CONSIDINE TERRY · director, 10 percent owner, officer: Chairman & CEO | A-Award | 181,737 | $20 |
| Jan 31, 2008 | RHODES THOMAS L · director | A-Award | 1,750 | $0.00 |
| Feb 2, 2007 | BLATZ ROBERT G · officer: President and COO | A-Award | 35,000 | $28 |
| Feb 2, 2007 | BLATZ ROBERT G · officer: President and COO | A-Award | 2,231 | $28 |
| Feb 2, 2007 | BLATZ ROBERT G · officer: President and COO | A-Award | 26,810 | $28 |
| Feb 2, 2007 | CONSIDINE TERRY · director, officer: Chairman & CEO | A-Award | 3,367 | $0.00 |
| Feb 2, 2007 | CONSIDINE TERRY · director, officer: Chairman & CEO | A-Award | 80,429 | $28 |
| Feb 2, 2007 | CONSIDINE TERRY · director, officer: Chairman & CEO | A-Award | 5,000 | $0.00 |
| Feb 1, 2007 | RHODES THOMAS L · director | A-Award | 1,400 | $28 |
| Apr 28, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 750 | $27 |
| Apr 25, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 500 | $27 |
| Apr 24, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 500 | $27 |
| Apr 21, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 500 | $27 |
| Apr 21, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 550 | $27 |
| Apr 19, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 250 | $27 |
| Apr 14, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 150 | $27 |
| Apr 14, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 100 | $27 |
| Apr 13, 2006 | BLATZ ROBERT G · officer: President and COO | Sale | 100 | $27 |
Institutional positioning
13F filings over the trailing two quarters
New 44Increased 11Reduced 7Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Cormorant Asset Management, LP | Increased | 3,978,229 | Aug 14, 2026 |
| VR ADVISER, LLC | New Position | 3,212,731 | May 15, 2026 |
| VR Adviser, LLC | Unchanged | 3,212,731 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 3,061,668 | Aug 14, 2026 |
| CORMORANT ASSET MANAGEMENT, LP | New Position | 2,897,857 | May 15, 2026 |
| Point72 Asset Management, L.P. | New Position | 2,140,664 | Aug 14, 2026 |
| MPM BioImpact LLC | New Position | 1,936,291 | Aug 14, 2026 |
| PERCEPTIVE ADVISORS LLC | New Position | 1,793,190 | Aug 14, 2026 |
| Squadron Capital Management LLC | New Position | 1,265,231 | May 15, 2026 |
| Casdin Capital, LLC | Increased | 1,250,000 | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | Increased | 1,017,805 | Aug 14, 2026 |
| Octagon Capital Advisors LP | New Position | 934,716 | Aug 14, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | New Position | 877,846 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 807,832 | Aug 14, 2026 |
| BRAIDWELL LP | New Position | 795,214 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026